CAM
Cormorant Asset Management’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,142,079
| Closed | -$35M | – | 48 |
|
|
2024
Q1 | $35M | Hold |
3,142,079
| – | – | 1.54% | 19 |
|
|
2023
Q4 | $46.8M | Buy |
3,142,079
+2,530,000
| +413% | +$37.7M | 2.23% | 11 |
|
|
2023
Q3 | $2.94M | Hold |
612,079
| – | – | 0.17% | 43 |
|
|
2023
Q2 | $4.6M | Hold |
612,079
| – | – | 0.26% | 49 |
|
|
2023
Q1 | $2.77M | Hold |
612,079
| – | – | 0.18% | 58 |
|
|
2022
Q4 | $6.9M | Sell |
612,079
-100,000
| -14% | -$1.13M | 0.46% | 46 |
|
|
2022
Q3 | $6.82M | Hold |
712,079
| – | – | 0.48% | 46 |
|
|
2022
Q2 | $5.76M | Hold |
712,079
| – | – | 0.44% | 49 |
|
|
2022
Q1 | $12M | Sell |
712,079
-50,000
| -7% | -$845K | 0.92% | 31 |
|
|
2021
Q4 | $16.4M | Sell |
762,079
-250,000
| -25% | -$5.37M | 0.97% | 29 |
|
|
2021
Q3 | $74.8M | Buy |
1,012,079
+122,625
| +14% | +$9.06M | 3.04% | 9 |
|
|
2021
Q2 | $48.6M | Buy |
889,454
+7,684
| +0.9% | +$420K | 1.65% | 13 |
|
|
2021
Q1 | $65M | Hold |
881,770
| – | – | 1.45% | 12 |
|
|
2020
Q4 | $76M | Sell |
881,770
-90,000
| -9% | -$7.76M | 1.81% | 11 |
|
|
2020
Q3 | $36M | Buy |
+971,770
| New | +$36M | 1.38% | 21 |
|